6-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-2-(3,5-dimethylpiperazin-1-yl)-4-fluoro-1,3-benzothiazole;hydrochloride
C21H24ClFN6S — CID 153383443
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-2-(3,5-dimethylpiperazin-1-yl)-4-fluoro-1,3-benzothiazole;hydrochloride
6-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-2-(3,5-dimethylpiperazin-1-yl)-4-fluoro-1,3-benzothiazole;hydrochloride (PubChem CID 153383443) has the molecular formula C21H24ClFN6S and a molecular weight of 446.98 g/mol. Its IUPAC name is 6-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-2-(3,5-dimethylpiperazin-1-yl)-4-fluoro-1,3-benzothiazole;hydrochloride.
Molecular Properties
| Compound Name | 6-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-2-(3,5-dimethylpiperazin-1-yl)-4-fluoro-1,3-benzothiazole;hydrochloride |
|---|---|
| PubChem CID | 153383443 |
| Molecular Formula | C21H24ClFN6S |
| Molecular Weight | 446.98 g/mol |
| Exact Mass | 446.15 |
| IUPAC Name | 6-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-2-(3,5-dimethylpiperazin-1-yl)-4-fluoro-1,3-benzothiazole;hydrochloride |
| SMILES | Cc1cn2nc(-c3cc(F)c4nc(N5CC(C)NC(C)C5)sc4c3)cc(C)c2n1.Cl |
| InChI | InChI=1S/C21H23FN6S.ClH/c1-11-5-17(26-28-10-14(4)24-20(11)28)15-6-16(22)19-18(7-15)29-21(25-19)27-8-12(2)23-13(3)9-27;/h5-7,10,12-13,23H,8-9H2,1-4H3;1H |
| InChIKey | SPRCJASXWUOXHP-UHFFFAOYSA-N |
| XLogP | 4.37 |
| TPSA | 58.35 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.98 |
| LogP ≤ 5 | 4.37 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153383443 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.